Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2015 Nov 11;25(5):493–502. doi: 10.1002/pds.3902

Table 3.

Propensity for use of triptans in pregnancy for the main (“MoBa”) study and the external validation study (“MIMEGA”)

MoBa Study MIMEGA Study
Odds Ratio 95% Confidence Interval Odds Ratio 95% Confidence Interval
Age in years1 1.0 1.0 to 1.1 1.0 1.0 to 1.1
BMI (kg/m2)
<18.5 0.8 0.4 to 1.5 -- --
18.5-25 REF -- --
>25 1.1 0.9 to 1.4 -- --
Multiparous 0.9 0.7 to 1.1 0.5 0.2 to 1.0
Married or cohabitating 0.6 0.4 to 1.0 0.7 0.2 to 2.6
Mother Education
University or higher vs. other categories 0.8 0.6 to 1.0 1.5 0.8 to 2.9
Smoking during pregnancy 0.9 0.7 to 1.3 1.4 0.4 to 4.1
Alcohol during pregnancy 1.4 1.1 to 1.9 5.2 1.4 to 19.2
Folate Supplementation 1.1 0.9 to 1.4 1.3 0.5 to 3.4
Medications Taken In Pregnancy
Opioids 2.9 2.1 to 4.1 3.1 1.4 to 6.6
Acetaminophen 1.7 1.3 to 2.2 1.9 0.9 to 4.0
NSAIDs 2.1 1.6 to 2.7 4.9 2.2 to 11.1
Anticonvulsants 0.9 0.1 to 6.6 -- --
Antidepressants 1.1 0.5 to 2.6 -- --
Benzodiazepines 2.6 1.0 to 6.9 -- --
Medications Before Pregnancy
Triptans 21.4 16.1 to 28.5 27.9 3.8 to 204.9
Opioids 1.5 1.0 to 2.3 1.2 0.6 to 2.6
Acetaminophen 1.0 0.8 to 1.3 1.5 0.8 to 3.1
NSAIDs 0.9 0.7 to 1.2 1.1 0.6 to 2.1
Anticonvulsants 1.9 0.4 to 8.4 -- --
Antidepressants 1.3 0.8 to 2.1 -- --
Benzodiazepines 1.6 0.7 to 3.8 -- --
Maternal Depression 1.0 0.7 to 1.4 2.2 0.7 to 6.9
Migraine Type
With Aura vs Other/Don’t know -- -- 1.1 0.5 to 2.6
Without Aura vs Other/Don’t know -- -- 1.8 0.8 to 4.1
Migraine Severity Score (MIGSEV) 1 -- -- 1.2 1.1 to 1.4
Beliefs About Medicines Questionnaire (BMQ): Necessity Subscale 1 -- -- 1.2 1.1 to 1.3
Beliefs About Medicines Questionnaire (BMQ): Concern Subscale 1 -- -- 1.1 1.0 to 1.2
1

Odds of triptan use in pregnancy associated with a one-unit increase in age, MIGSEV score or BMQ score